Literature DB >> 19565319

Adenosine A(2A) receptor gene (ADORA2A) variants may increase autistic symptoms and anxiety in autism spectrum disorder.

Christine M Freitag1, Konstantin Agelopoulos, Ellen Huy, Matthias Rothermundt, Petra Krakowitzky, Jobst Meyer, Jürgen Deckert, Alexander von Gontard, Christa Hohoff.   

Abstract

Autism spectrum disorders (ASDs) are heterogeneous disorders presenting with increased rates of anxiety. The adenosine A(2A) receptor gene (ADORA2A) is associated with panic disorder and is located on chromosome 22q11.23. Its gene product, the adenosine A(2A) receptor, is strongly expressed in the caudate nucleus, which also is involved in ASD. As autistic symptoms are increased in individuals with 22q11.2 deletion syndrome, and large 22q11.2 deletions and duplications have been observed in ASD individuals, in this study, 98 individuals with ASD and 234 control individuals were genotyped for eight single-nucleotide polymorphisms in ADORA2A. Nominal association with the disorder was observed for rs2236624-CC, and phenotypic variability in ASD symptoms was influenced by rs3761422, rs5751876 and rs35320474. In addition, association of ADORA2A variants with anxiety was replicated for individuals with ASD. Findings point toward a possible mediating role of ADORA2A variants on phenotypic expression in ASD that need to be replicated in a larger sample.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19565319     DOI: 10.1007/s00787-009-0043-6

Source DB:  PubMed          Journal:  Eur Child Adolesc Psychiatry        ISSN: 1018-8827            Impact factor:   4.785


  25 in total

Review 1.  Central adenosine A(2A) receptors: an overview.

Authors:  J L Moreau; G Huber
Journal:  Brain Res Brain Res Rev       Date:  1999-12

2.  A comparison of bayesian methods for haplotype reconstruction from population genotype data.

Authors:  Matthew Stephens; Peter Donnelly
Journal:  Am J Hum Genet       Date:  2003-10-20       Impact factor: 11.025

3.  Association between A2a receptor gene polymorphisms and caffeine-induced anxiety.

Authors:  Karen Alsene; Jürgen Deckert; Philipp Sand; Harriet de Wit
Journal:  Neuropsychopharmacology       Date:  2003-06-25       Impact factor: 7.853

4.  Structural variation of chromosomes in autism spectrum disorder.

Authors:  Christian R Marshall; Abdul Noor; John B Vincent; Anath C Lionel; Lars Feuk; Jennifer Skaug; Mary Shago; Rainald Moessner; Dalila Pinto; Yan Ren; Bhooma Thiruvahindrapduram; Andreas Fiebig; Stefan Schreiber; Jan Friedman; Cees E J Ketelaars; Yvonne J Vos; Can Ficicioglu; Susan Kirkpatrick; Rob Nicolson; Leon Sloman; Anne Summers; Clare A Gibbons; Ahmad Teebi; David Chitayat; Rosanna Weksberg; Ann Thompson; Cathy Vardy; Vicki Crosbie; Sandra Luscombe; Rebecca Baatjes; Lonnie Zwaigenbaum; Wendy Roberts; Bridget Fernandez; Peter Szatmari; Stephen W Scherer
Journal:  Am J Hum Genet       Date:  2008-01-17       Impact factor: 11.025

5.  Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease.

Authors:  J Deckert; M M Nöthen; P Franke; C Delmo; J Fritze; M Knapp; W Maier; H Beckmann; P Propping
Journal:  Mol Psychiatry       Date:  1998-01       Impact factor: 15.992

6.  The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.

Authors:  C Lord; S Risi; L Lambrecht; E H Cook; B L Leventhal; P C DiLavore; A Pickles; M Rutter
Journal:  J Autism Dev Disord       Date:  2000-06

Review 7.  The genetics of autistic disorders and its clinical relevance: a review of the literature.

Authors:  C M Freitag
Journal:  Mol Psychiatry       Date:  2006-10-10       Impact factor: 15.992

8.  The role of the D(2) dopamine receptor (D(2)R) in A(2A) adenosine receptor (A(2A)R)-mediated behavioral and cellular responses as revealed by A(2A) and D(2) receptor knockout mice.

Authors:  J F Chen; R Moratalla; F Impagnatiello; D K Grandy; B Cuellar; M Rubinstein; M A Beilstein; E Hackett; J S Fink; M J Low; E Ongini; M A Schwarzschild
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

9.  Comorbid psychiatric disorders in children with autism: interview development and rates of disorders.

Authors:  Ovsanna T Leyfer; Susan E Folstein; Susan Bacalman; Naomi O Davis; Elena Dinh; Jubel Morgan; Helen Tager-Flusberg; Janet E Lainhart
Journal:  J Autism Dev Disord       Date:  2006-10

10.  Strong association of de novo copy number mutations with autism.

Authors:  Jonathan Sebat; B Lakshmi; Dheeraj Malhotra; Jennifer Troge; Christa Lese-Martin; Tom Walsh; Boris Yamrom; Seungtai Yoon; Alex Krasnitz; Jude Kendall; Anthony Leotta; Deepa Pai; Ray Zhang; Yoon-Ha Lee; James Hicks; Sarah J Spence; Annette T Lee; Kaija Puura; Terho Lehtimäki; David Ledbetter; Peter K Gregersen; Joel Bregman; James S Sutcliffe; Vaidehi Jobanputra; Wendy Chung; Dorothy Warburton; Mary-Claire King; David Skuse; Daniel H Geschwind; T Conrad Gilliam; Kenny Ye; Michael Wigler
Journal:  Science       Date:  2007-03-15       Impact factor: 47.728

View more
  28 in total

1.  Impact of genetic variations in ADORA2A gene on depression and symptoms: a cross-sectional population-based study.

Authors:  Sílvia Oliveira; Ana Paula Ardais; Clarissa Ribeiro Bastos; Marta Gazal; Karen Jansen; Luciano de Mattos Souza; Ricardo Azevedo da Silva; Manuella Pinto Kaster; Diogo Rizzato Lara; Gabriele Ghisleni
Journal:  Purinergic Signal       Date:  2018-12-03       Impact factor: 3.765

2.  Risk factors of autistic symptoms in children with ADHD.

Authors:  Anne Kröger; Susann Hänig; Christiane Seitz; Haukur Palmason; Jobst Meyer; Christine M Freitag
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-10-16       Impact factor: 4.785

3.  ADORA2A Gene variation, caffeine, and emotional processing: a multi-level interaction on startle reflex.

Authors:  Katharina Domschke; Agnieszka Gajewska; Bernward Winter; Martin J Herrmann; Bodo Warrings; Andreas Mühlberger; Katherina Wosnitza; Evelyn Glotzbach; Annette Conzelmann; Andrea Dlugos; Manfred Fobker; Christian Jacob; Volker Arolt; Andreas Reif; Paul Pauli; Peter Zwanzger; Jürgen Deckert
Journal:  Neuropsychopharmacology       Date:  2011-10-19       Impact factor: 7.853

Review 4.  Adenosine and autism: a spectrum of opportunities.

Authors:  Susan A Masino; Masahito Kawamura; Jessica L Cote; Rebecca B Williams; David N Ruskin
Journal:  Neuropharmacology       Date:  2012-08-24       Impact factor: 5.250

5.  Association of the anxiogenic and alerting effects of caffeine with ADORA2A and ADORA1 polymorphisms and habitual level of caffeine consumption.

Authors:  Peter J Rogers; Christa Hohoff; Susan V Heatherley; Emma L Mullings; Peter J Maxfield; Richard P Evershed; Jürgen Deckert; David J Nutt
Journal:  Neuropsychopharmacology       Date:  2010-06-02       Impact factor: 7.853

Review 6.  Astrocytic adenosine: from synapses to psychiatric disorders.

Authors:  Dustin J Hines; Philip G Haydon
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2014-10-19       Impact factor: 6.237

7.  A novel copy number variants kernel association test with application to autism spectrum disorders studies.

Authors:  Xiang Zhan; Santhosh Girirajan; Ni Zhao; Michael C Wu; Debashis Ghosh
Journal:  Bioinformatics       Date:  2016-08-06       Impact factor: 6.937

Review 8.  Purinergic system in psychiatric diseases.

Authors:  A Cheffer; A R G Castillo; J Corrêa-Velloso; M C B Gonçalves; Y Naaldijk; I C Nascimento; G Burnstock; H Ulrich
Journal:  Mol Psychiatry       Date:  2017-09-26       Impact factor: 15.992

9.  Modification of caffeine effects on the affect-modulated startle by neuropeptide S receptor gene variation.

Authors:  Katharina Domschke; Benedikt Klauke; Bernward Winter; Agnes Gajewska; Martin J Herrmann; Bodo Warrings; Andreas Mühlberger; Katherina Wosnitza; Andrea Dlugos; Swantje Naunin; Kathrin Nienhaus; Manfred Fobker; Christian Jacob; Volker Arolt; Paul Pauli; Andreas Reif; Peter Zwanzger; Jürgen Deckert
Journal:  Psychopharmacology (Berl)       Date:  2012-03-08       Impact factor: 4.530

10.  Analysis of Extracellular Nucleotide Metabolism in Adult Zebrafish After Embryological Exposure to Valproic Acid.

Authors:  Fernanda Francine Zimmermann; Karina Vidarte Gaspary; Anna Maria Siebel; Carlos Eduardo Leite; Luiza Wilges Kist; Mauricio Reis Bogo; Carla Denise Bonan
Journal:  Mol Neurobiol       Date:  2016-05-17       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.